News

Cigna’s first-quarter report shows strong numbers, but Barclays warns the road ahead could get rocky. Barclays highlights ...
Citigroup (C -0.30%) is one of the best-known banks in the United States and probably the world. But it doesn't have the best ...
Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...
UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...
Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...
Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...
Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 ...
Detailed price information for Onkure Therapeutics Inc (OKUR-Q) from The Globe and Mail including charting and trades.
We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where The Cigna Group ... have used the ratings by ...
On Monday, Raymond (NSE: RYMD) James increased its price target on shares of CIGNA (NYSE: CI) to $385 from the previous target of $360, while reiterating a Strong Buy rating on the stock.With a market ...
Cigna’s stock price target increase at Jefferies reflects a vote of confidence in the company’s ability to maintain its strong performance and deliver value to shareholders.